Atlas FDA

Oxford™ Cementless Partial Knee System

FDA premarket approval P010014/S105 · decided 2024-11-22

Approval details

PMA number
P010014
Supplement
S105
Supplement type
Panel Track
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Oxford™ Cementless Partial Knee System
Generic name
Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing
Applicant
Biomet Manufacturing Corp
Date received
2023-06-05
Decision date
2024-11-22
Days to decision
536 days
Decision code
APPR
Product code
NRA
Advisory committee
Orthopedic
Expedited review
No
Location
Warsaw, IN
Statement
The Oxford Cementless Partial Knee System is indicated for use in unilateral knee procedures with osteoarthritis or avascular necrosis limited to the medial compartment of the knee. It is intended to be implanted without the application of bone cement for patients whose clinical condition would benefit from a shorter surgical time compared to the cemented implant.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Patient Specific Planning Solution™ 3D Bone Models (K230540)Biomet Manufacturing Corp2023-07-25
Comprehensive® Shoulder System, Comprehensive® Reverse Shoulder System (K214001)Biomet Manufacturing Corp2023-03-15
Comprehensive® Convertible Glenoid - Vivacit-E Liner (K211729)Biomet Manufacturing Corp2021-11-04
Comprehensive Vault Reconstruction System (K202232)Biomet Manufacturing Corp2021-02-19
Comprehensive Shoulder System (K193038)Biomet Manufacturing Corp2020-10-28
Comprehensive Nano Stemless Shoulder (K182516)Biomet Manufacturing Corp2019-04-22
Comprehensive Reverse Shoulder System (K181611)Biomet Manufacturing Corp2018-09-24
Comprehensive Segmental Revision System (SRS) (K173411)Biomet Manufacturing Corp2018-02-08